Free Trial

Inhibikase Therapeutics (IKT) Stock Trends and Sentiment

Inhibikase Therapeutics logo
$1.97 -0.01 (-0.51%)
(As of 09:30 AM ET)

Media Mentions Over Time



View Trending Media Stocks

MarketBeat New Followers Over Time

MarketBeat Searches Over Time



Page Views Over Time



Recieve Inhibikase Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for IKT and its competitors with MarketBeat's FREE daily newsletter.

IKT Social Media Mentions

Related Companies and Tools


This page (NYSE:IKT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners